IO Biotech, Inc. (IOBT)
IOBT Stock Price Chart
Explore IO Biotech, Inc. interactive price chart. Choose custom timeframes to analyze IOBT price movements and trends.
IOBT Company Profile
Discover essential business fundamentals and corporate details for IO Biotech, Inc. (IOBT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Nov 2021
Employees
80.00
Website
https://www.iobiotech.comCEO
Mai-Britt Zocca
Description
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.
IOBT Financial Timeline
Browse a chronological timeline of IO Biotech, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.34.
Earnings released on 14 Aug 2025
EPS came in at -$0.40 falling short of the estimated -$0.35 by -14.29%.
Earnings released on 14 May 2025
EPS came in at -$0.34 surpassing the estimated -$0.45 by +24.44%.
Earnings released on 25 Mar 2025
EPS came in at -$0.48 falling short of the estimated -$0.38 by -25.16%.
Earnings released on 12 Nov 2024
EPS came in at -$0.36 falling short of the estimated -$0.29 by -24.14%.
Earnings released on 13 Aug 2024
EPS came in at -$0.31 surpassing the estimated -$0.34 by +8.82%.
Earnings released on 14 May 2024
EPS came in at -$0.30 surpassing the estimated -$0.37 by +18.92%.
Earnings released on 5 Mar 2024
EPS came in at -$0.40 falling short of the estimated -$0.36 by -11.11%, while revenue for the quarter reached $1.11M .
Earnings released on 13 Nov 2023
EPS came in at -$0.43 surpassing the estimated -$0.47 by +8.51%.
Earnings released on 11 Aug 2023
EPS came in at -$0.74 falling short of the estimated -$0.66 by -12.12%.
Earnings released on 11 May 2023
EPS came in at -$0.59 surpassing the estimated -$0.72 by +18.06%.
Earnings released on 14 Mar 2023
EPS came in at -$0.69 falling short of the estimated -$0.57 by -21.05%.
Earnings released on 9 Nov 2022
EPS came in at -$0.56 surpassing the estimated -$0.73 by +23.29%.
Earnings released on 11 Aug 2022
EPS came in at -$0.64 surpassing the estimated -$0.65 by +1.54%.
Earnings released on 16 May 2022
EPS came in at -$0.60 surpassing the estimated -$0.69 by +13.04%.
Earnings released on 31 Dec 2021
EPS came in at -$0.83 .
Earnings released on 17 Dec 2021
EPS came in at -$36.88 falling short of the estimated -$1.60 by -2.21K%.
Earnings released on 30 Jun 2021
EPS came in at -$3.32 .
Earnings released on 31 Mar 2021
EPS came in at -$0.32 .
Earnings released on 31 Dec 2020
EPS came in at -$0.22 .
Earnings released on 30 Sept 2020
EPS came in at -$0.30 .
IOBT Stock Performance
Access detailed IOBT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.